Sinocare(SZ:300298) Jiang Nan Shi Bao·2025-11-28 06:53Core Insights - The MEDICA exhibition in Düsseldorf, Germany, is recognized as the world's largest B2B trade fair for the medical industry, showcasing significant innovations in diabetes management, particularly by Sinocare with its second-generation dynamic blood glucose monitor [1][6] Group 1: Product Innovation - Sinocare's second-generation dynamic blood glucose monitor features a MARD value of 8.71%, surpassing the industry standard of 15%, providing reliable data for diabetes management [2] - The device can monitor glucose levels continuously for 15 days with automatic readings every 3 minutes, yielding approximately 7200 data points per wear [3] Group 2: User Experience and Features - The monitor's design includes IP28-rated waterproof and dustproof features, enhancing user comfort and usability in daily life [2] - Users can access glucose fluctuation curves through the Sinocare app, receive alerts for abnormal glucose levels, and benefit from 24-hour professional consultation services [3] Group 3: Market Impact - The successful presentation of Sinocare's monitor at MEDICA highlights China's growing influence in the global health industry and the company's commitment to improving life quality for diabetes patients [6]